Three in Four Prisons Won't Say Whether They Treat Opioid Addiction. Release Day Is When That Silence Kills.

If someone you love is sitting in a county jail tonight on buprenorphine or methadone, try to find out, from the jail’s own website, whether they will keep getting it. In most of the country you will not be able to. A study published November 3 in JAMA Network Open went looking for exactly that information across 1,746 prisons and 2,920 jails. Only 447 prisons, 25.6%, and 396 jails, 13.6%, had any public record confirming they offer medication for opioid use disorder at all.

A jail that will not tell you whether it treats addiction has already told you how much it plans to.

The details are worse than the headline. Among jails that do report something, only about one in six said they offer all three approved medications. A third of them reported naltrexone alone, the one medication that does not replace the opioid and requires a person to be fully through withdrawal first. In plain terms, many jails that say they “offer treatment” offer the version that is easiest to run and hardest to start. Not one facility publicly said it does not offer medication, which tells you nobody wants to be on record. The researchers, led by Justin Berk at Brown with senior author Josiah Rich, are careful about the limit: a jail with no public record might still run a program, so these numbers are a floor. Their ask is simple: uniform, public reporting, which accreditation standards do not currently require.

Why it matters has been known for almost twenty years. A 2007 study in the New England Journal of Medicine found that people leaving Washington State prisons died at sharply elevated rates in the first two weeks out, overdose leading the list. Tolerance drops behind bars; the supply outside does not wait. When Rhode Island started offering all three medications across its corrections system, Rich’s team reported in JAMA Psychiatry that the share of the state’s overdose deaths among recently released people fell 60.5% in a year. That is one state and one before-and-after comparison, but it is the clearest signal in the field.

For case managers and reentry staff, the move this week: for every client with a release date, call the facility and ask in writing which medication they are on and whether they leave with a dose, a prescription and an appointment. Put the answer in the chart. If you are the one getting out, ask for naloxone at the door, and ask for your next dose before you ask for anything else. Our opioids hub and treatment coverage track the fight over methadone access outside the walls too.

The first two weeks out are the most dangerous days a person with opioid use disorder will live. Nobody should walk into them because a website stayed blank.